SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Trump For President

The TRUMP ticker is experiencing intense volatility and social media backlash, driven by community skepticism regarding its association with the administration and frequent accusations of a "pump and dump" scheme. Investors are actively debating the token's long-term viability, with many critics highlighting its sharp price decline and drawing unfavorable comparisons to broader political controversies.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor Therapeutics is trending as investors react to the FDA lifting the hold on its Biologics License Application for Deramiocel and establishing a PDUFA date for August 2026. The community is focused on the potential for an earlier-than-expected approval, positive data readouts, and the company's long-term potential in the rare disease and exosome platform space.

MARA Holdings, Inc. is a digital asset technology company, which engages in mining cryptocurrencies with a focus on the Bitcoin ecosystem. It also deals with owning and operating bitcoin mining facilities or data centers, selling proprietary software or technology to third parties operating in the Bitcoin ecosystem, offering advisory and consulting services to support Bitcoin mining ventures in domestic and international jurisdictions, and generating electricity from renewable energy resources or methane gas capture to power Bitcoin mining projects. The company was founded on February 23, 2010 and is headquartered in Hallandale Beach, FL.

MARA Holdings Inc.

Marathon Digital Holdings Inc

Marathon Digital is facing intense scrutiny as investors weigh its pivot into AI data centers against a persistent pattern of underperformance compared to broader crypto markets. The community remains deeply divided, with bulls pointing to undervalued assets and potential institutional accumulation, while skeptical traders and bears frequently criticize management's execution and the stock's tendency to amplify downside volatility.

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracle is seeing intense trading activity as investors react to a strong quarterly earnings report featuring a massive increase in remaining performance obligations and bullish AI infrastructure guidance. While community sentiment is divided between optimism over long-term cloud demand and skepticism regarding persistent short selling and market manipulation, many are closely monitoring key technical levels and analyst price target revisions.

Meta Platforms, Inc. engages in the development of social media applications. It builds technology that helps people connect and share, find communities, and grow businesses. It operates through the Family of Apps (FoA) and Reality Labs (RL) segments. The FoA segment consists of Facebook, Instagram, Messenger, WhatsApp, and other services. The RL segment includes augmented, mixed and virtual reality related consumer hardware, software, and content. The company was founded by Mark Elliot Zuckerberg, Dustin Moskovitz, Chris R. Hughes, Andrew McCollum, and Eduardo P. Saverin on February 4, 2004, and is headquartered in Menlo Park, CA.

Meta Platforms Inc - Ordinary Shares - Class A

Meta Platforms Inc

Meta is facing intense market volatility as investors weigh the delayed rollout of its "Avocado" AI model against news of a potential shift in its massive data center infrastructure strategy. While some traders are expressing frustration over the recent downward price action and persistent spending concerns, others view the current dip as a strategic buying opportunity, pointing to the company's aggressive in-house chip development and long-term ad revenue growth as key pillars for future stability.

Vanguard Index Funds - Vanguard S&P 500 ETF

Vanguard S&P 500 ETF

Vanguard S&P 500 ETF (VOO) is trending as retail traders actively debate the volatility of AI-driven semiconductor exposure and broader market sentiment ahead of key economic data. The community is focused on the tension between long-term passive accumulation and short-term hedging strategies using inverse ETFs to exploit structural decay.

Lennar Corp. engages in the provision of real estate related financial and investment management services. It operates through the following segments: Homebuilding, Financial Services, Multifamily, and Lennar Other. The Homebuilding segment refers to the construction and sale of single-family attached and detached homes and the purchase, development, and sale of residential land directly and through entities. The Financial Services segment focuses on mortgage financing, title, and closing services for buyers. The Multifamily segment is involved in the development, construction, and property management of multifamily rental properties. The Lennar Other segment includes funds, asset management platform, and strategic investments in technology companies. The company was founded in 1954 and is headquartered in Miami, FL.

Lennar Corp. - Ordinary Shares - Class A

Lennar Corp.

Lennar is in the spotlight as investors weigh the company's recent earnings results and future guidance against the broader backdrop of persistent housing affordability challenges and shifting interest rate expectations. The community remains deeply divided, with some traders eyeing a potential short squeeze on fundamentally strong housing plays, while others express concerns that elevated home prices and high input costs could lead to further downside.

Ulta Beauty, Inc. engages in the retail of beauty products. The company has one reportable segment, which includes retail stores, salon services, and e-commerce. Its products include makeup, skin care, tools and brushes, fragrance, and bath and body. The company was founded on January 9, 1990 and is headquartered in Bolingbrook, IL.

Ulta Beauty Inc

Ulta Beauty is experiencing significant volatility following a mixed earnings report where a top-line beat and guidance hike were offset by concerns over the company's long-term growth trajectory and margin pressures. Community sentiment is deeply divided, with some traders viewing the post-earnings pullback as a prime buying opportunity for a resilient consumer brand, while others highlight the stock's elevated valuation and recent technical weakness as reasons to remain bearish.

Babcock & Wilcox Enterprises, Inc. engages in the provision of fossil and renewable power generation and environmental equipment. It operates through the following segments: B&W Renewable, B&W Environmental, and B&W Thermal. The B&W Renewable segment supports a circular economy, diverting waste from landfills to use for power generation and replacing fossil fuels, while recovering metals and reducing emissions. The B&W Environmental segment focuses on systems for cooling, ash handling, particulate control, nitrogen oxides and sulfur dioxides removal, chemical looping for carbon control, and mercury control. The B&W Thermal segment offers steam generation equipment, aftermarket parts, construction, maintenance, and field services for plants in the power generation, oil and gas, and industrial sectors. The company was founded by George H. Babcock, Stephen Wilcox, Jr., and Joseph P. Manton in 1856 and is headquartered in Akron, OH.

Babcock & Wilcox Enterprises Inc

Babcock & Wilcox is trending as investors rally behind its repositioning as a key infrastructure provider for AI data centers, fueled by a series of new project awards and successful debt reduction efforts. The community remains focused on the potential for major contract catalysts in the upcoming quarters and the stock's recent strong momentum as a play on surging power demand.

Rubrik, Inc. engages in the provision of cloud data management solutions. Its solutions include backup and recovery, VM backup, Microsoft 365, ransom ware recovery, database backup, cloud solutions, and Polaris sonar. Rubrik products include data protection, data threat analytics, data security posture and cyber recovery. The company was founded by Bipul Sinha, Arvind Jain, Soham Mazumdar, and Arvind Nithrakashyap in December 2013 and is headquartered in Palo Alto, CA.

Rubrik Inc. - Ordinary Shares - Class A

Rubrik Inc. - Class A

Rubrik is facing significant downward volatility as market participants express frustration over price action and perceived manipulation, despite the company's strong revenue growth and expanding footprint in AI-driven data security. Investors are actively debating whether current valuation concerns and sector-wide weakness are temporary setbacks or fundamental risks, leading to heated discussions about the sustainability of their business model versus broader enterprise adoption.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Quadrature Capital Ltd Boosts Stock Holdings in argenex SE $ARGX

Quadrature Capital Ltd raised its position in shares of argenex SE (NASDAQ:ARGX - Free Report) by 146.8% in the third quarter, according to its most recent Form 13F filing with the Securities and...

Van ECK Associates Corp Sells 5,527 Shares of argenex SE $ARGX

Van ECK Associates Corp lessened its stake in shares of argenex SE (NASDAQ:ARGX - Free Report) by 13.3% in the 3rd quarter, according to its most recent disclosure with the SEC. The institutional...

argenex SE $ARGX Shares Purchased by Natixis Advisors LLC

Natixis Advisors LLC raised its holdings in shares of argenex SE (NASDAQ:ARGX - Free Report) by 28.5% in the 3rd quarter, according to the company in its most recent disclosure with the Securities...

First Trust Advisors LP Acquires 6,215 Shares of argenex SE $ARGX

First Trust Advisors LP grew its holdings in shares of argenex SE (NASDAQ:ARGX - Free Report) by 10.6% in the third quarter, according to its most recent Form 13F filing with the Securities and...

Sands Capital Management LLC Takes $12.26 Million Position in argenex SE $ARGX

Sands Capital Management LLC bought a new position in shares of argenex SE (NASDAQ:ARGX - Free Report) in the 3rd quarter, according to the company in its most recent filing with the Securities and...

Capital World Investors Buys 8,422 Shares of argenex SE $ARGX

Capital World Investors increased its holdings in shares of argenex SE (NASDAQ:ARGX - Free Report) by 0.4% during the third quarter, according to its most recent 13F filing with the Securities and...

Capital International Sarl Invests $1.36 Million in argenex SE $ARGX

Capital International Sarl acquired a new stake in argenex SE (NASDAQ:ARGX - Free Report) in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission...

argenex (NASDAQ:ARGX) Upgraded by Deutsche Bank Aktiengesellschaft to Buy Rating

Deutsche Bank Aktiengesellschaft raised argenex from a "hold" rating to a "buy" rating in a report on Tuesday...

<ul class="summary-bullets"><li>The “go” decision was reached early, ahead of the company’s second quarter expected timeline.</li><li>The results from the interim analysis appear stronger than those reported by Sanofi's experimental drug riliprubart in its open-label mid-stage CIDP study, Truist said.</li><li>H.C. Wainwright increased its view of the probability of launch for claseprubart to 35% from a previous 26%.</li></ul>Shares of Dianthus Therapeutics, Inc. (DNTH) soared 19% on Monday after the company announced an early “go” decision for its experimental drug claseprubart in its Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) program, boosting Wall Street optimism.The company <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://investor.dianthustx.com/news-releases/news-release-details/dianthus-therapeutics-announces-early-go-decision-following">said</a> that the decision was based on an analysis of data from a part of its late-stage trial in which a response rate of 50% or greater was observed. Twenty or more responders were confirmed out of the first 40 participants to complete part A of the trial and no related serious infections or discontinuations were observed, the company said.The “go” decision was reached early, ahead of the company’s second quarter expected timeline, and confirmed by an independent Data Safety Monitoring Board review, it added.The decision supports continued development of claseprubart into the pivotal portion of the trial in CIDP, the company said. Dianthus Therapeutics said that it will maintain the dose as is in the part A portion of the trial and engage with regulators to remove a lower dose arm in the part B portion.Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) is a rare, acquired autoimmune disorder where the immune system damages the myelin sheath of peripheral nerves, causing progressive or relapsing muscle weakness, numbness, and sensory loss. Other firms developing drugs for the condition include Sanofi (SNY) and Argenx SE (ARGX).<h2 class="st-heading-2">Wall Street Responds</h2>Truist raised the firm's price target on Dianthus to $110 from $63 and kept a ‘Buy’ rating on the shares. The results from the interim analysis appear stronger than those reported by Sanofi's experimental drug riliprubart in its open-label mid-stage CIDP study, the analyst told investors in a research note.H.C. Wainwright analyst Swayampakula Ramakanth, meanwhile, raised the firm's price target on Dianthus to $130 from $47 and kept a ‘Buy’ rating on the shares. The firm increased its view of the probability of launch for claseprubart to 35% from a previous 26% and also raised its price estimate to $450,000 per patient per annum compared to its prior $250,000 estimate.TD Cowen, which views Dianthus as "a viable takeout target," also kept a ‘Buy’ rating on the shares.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>On Stocktwits, retail sentiment around DNTH stock jumped from ‘bullish’ to ‘extremely bullish’ territory over the past 24 hours, while message volume increased from ‘high’ to ‘extremely high’ levels.<a href="https://stocktwits.com/symbol/DNTH">DNTH stock</a> has more than tripled over the past 12 months.&nbsp;Read More: <a href="https://stocktwits.com/news-articles/markets/equity/jim-cramer-terrific-ai-stock-pick-gev-gets-double-upgrade/cZdVrjXRIIw">Jim Cramer's 'Terrific' AI Stock Pick Is Already Up 26% YTD, And It Just Received A Double Upgrade Today — Here's Why</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the Dianthus Therapeutics logo is seen displayed on a smartphone screen. (Photo Illustration by Thomas Fuller/SOPA Images/LightRocket via Getty Images)

DNTH Stock Soars After Early ‘Go’ Decision For Drug In Autoimmune Disorder Program, Boosting Wall Street Optimism For Potential Launch

Dianthus Therapeutics announced an early “go” decision for its experimental drug claseprubart in its Chronic Inflammatory Demyelinating Polyneuropathy program based on analysis of data from a part of its late-stage trial. 

Equity

argenex (NASDAQ:ARGX) Given "Outperform" Rating at Wedbush

Wedbush reiterated an "outperform" rating and issued a $1,000.00 price objective on shares of argenex in a research note on Monday...

argenx SE is a global immunology company, which engages in improving the lives of people suffering from severe autoimmune diseases. It operates through the following geographical segments: United States, Japan, EMEA, and China. The company was founded by Hans J. W. de Haard, Torsten Dreier, and Tim van Hauwermeiren in 2008 and is headquartered in Amsterdam, the Netherlands.

ARGX
Argenx

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest ARGX News

ARGXArgenx